A detailed history of River Park Advisors, LLC transactions in Artivion, Inc. stock. As of the latest transaction made, River Park Advisors, LLC holds 5,387 shares of AORT stock, worth $153,421. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,387
Previous 2,141 151.61%
Holding current value
$153,421
Previous $54,000 164.81%
% of portfolio
0.12%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$24.33 - $28.46 $78,975 - $92,381
3,246 Added 151.61%
5,387 $143,000
Q2 2024

Jul 26, 2024

BUY
$19.62 - $25.65 $42,006 - $54,916
2,141 New
2,141 $54,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.15B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track River Park Advisors, LLC Portfolio

Follow River Park Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Park Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Park Advisors, LLC with notifications on news.